In conclusion, we provide evidence for the first time that anticancer effect of TTB on diverse cancer cells result from the induction of ROS-mediated apoptosis by inhibiting of STAT3 phosphorylation and enhancing of DNA damage. The gene discussed is STAT3; the disease is cancer.